This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Goldman, D. P. Articles by Bozzette, S. A. Search for Related Content PubMed Articles by Goldman, D. P. Articles by Bozzette, S. A. Social Bookmarking                         What's this?

The Impact of State Policy on the Costs of HIV Infection

RAND

Jayanta Bhattacharya

RAND

Arleen A. Leibowitz

University of California, Los Angeles

Geoffrey F. Joyce

RAND

Martin F. Shapiro

University of California, Los Angeles

Samuel A. Bozzette

University of California, San Diego, and Veterans Affairs San Diego Healthware Systems

There is substantial variation in the generosity of public assistance programs that affect HIV+ patients, and these differences should affect the economic outcomes associated with HIV infection. This article uses data from a nationally representative sample of HIV+ patients to assess how differences across states in Medicaid and AIDS Drug Assistance Programs (ADAP) affect costs and labor market outcomes for HIV+ patients in care in that state. Making ADAP programs more generous in terms of drug coverage would reduce per patient total monthly costs, mainly through a reduction in hospitalization costs. In contrast, expanding ADAP eligibility by increasing the income threshold would increase the total cost of care. Expanding eligibility for Medicaid through the medically needy program would increase per patient total costs, but full-time employment would increase and so would monthly earnings. The authors conclude that more generous state policies toward HIV+ patients—especially those designed to provide access to efficacious treatment—could improve the economic outcomes associated with HIV.

Medical Care Research and Review, Vol. 58, No. 1, 31-53 (2001)
DOI: 10.1177/107755870105800102


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. S. Zingmond, S. L. Ettner, and W. E. Cunningham The Impact of Managed Care on Access to Highly Active Antiretroviral Therapy and on Outcomes among Medicaid Beneficiaries with AIDS Med Care Res Rev, February 1, 2007; 64(1): 66 - 82. [Abstract] [PDF]

				Z. Lazzarini and R. Klitzman HIV and the Law: Integrating Law, Policy, and Social Epidemiology J. Law Med. Ethics, December 1, 2002; 30(4): 533 - 547. [PDF]

				D. P. Goldman Erratum Med Care Res Rev, December 1, 2001; 58(4): 497 - 498. [PDF]

				P. S. Arno Commentary Med Care Res Rev, March 1, 2001; 58(1): 54 - 59. [PDF]